SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,339 | -48.9% | 29,134 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $135,701 | -17.1% | 28,330 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $163,750 | +4.4% | 28,880 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $156,845 | -9.3% | 28,008 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | +188.3% | 26,952 | +54.7% | 0.00% | +100.0% |
| Q2 2022 | $60,000 | -54.9% | 17,423 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $133,000 | -13.6% | 18,621 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $154,000 | +18.5% | 18,514 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $130,000 | -70.7% | 18,729 | +0.7% | 0.00% | -75.0% |
| Q2 2021 | $444,000 | +15.9% | 18,603 | +0.0% | 0.00% | +33.3% |
| Q1 2021 | $383,000 | -12.2% | 18,594 | +4.4% | 0.00% | -25.0% |
| Q4 2020 | $436,000 | – | 17,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |